Although the role of Elp3 in all stromal cells remains to be extensively defined, our data strengthen the notion that Elp3 is a promising therapeutic target to treat intestinal tumors showing constitutive Wnt signaling. This evidence concerns the gene ELP3 and intestinal neoplasm.